Cited by 131Phytochemicals and Medicinal PlantsCancer survivorship and careComplementary and Alternative Medicine Studies

Effect of Withania somnifera (Ashwagandha) on the Development of Chemotherapy-Induced Fatigue and Quality of Life in Breast Cancer Patients

Open access
Biswal, Biswa Mohan, Sulaiman, Siti Amrah, Ismail, Hasanah Che, Zakaria, Hasmat, Musa, Kamarul Imran·2013·Integrative Cancer Therapies

Abstract

UNLABELLED: Hypothesis. Withania somnifera is an herb with antioxidant, anti-inflammatory, anticancer, antistress, and adaptogenic properties. Previous studies have shown its antistress effects in animals. Traditional Indian medicine has used it for centuries to alleviate fatigue and improve general well-being. METHODS: This is an open-label prospective nonrandomized comparative trial on 100 patients with breast cancer in all stages undergoing either a combination of chemotherapy with oral Withania somnifera or chemotherapy alone. The chemotherapy regimens were either taxotere, adriamycin, and cyclophosphamide or 5-fluorouracil, epirubicin, and cyclophosphamide. Withania somnifera root extract was administered to patients in the study group at a dose of 2 g every 8 hours, throughout the course of chemotherapy. The quality-of-life and fatigue scores were evaluated before, during, and on the last cycles of chemotherapy using the EORTC QLQ-C30 (Version 3), Piper Fatigue Scale (PFS), and Schwartz Cancer Fatigue Scale (SCFS-6). RESULTS: The median age distributions in the study and control arm were 51 years (range = 36-70) and 50.5 years (range = 32-71), respectively. The majority (77%) of patients had stage II and III disease. Patients in the control arm experienced statistically significant higher estimated marginal means of fatigue score compared with the study group (P < .001 PFS, P < .003 SCFS-6). Furthermore, various symptom scales of the EORTC QLQ-C30 were statistically significant in 7 out of 18 symptoms in the intervention group compared with the control group (P < .001). The 24-month overall survival for all stages in study and control group patients were 72% versus 56%, respectively; however, the result was not significant (P = .176), at a median follow-up duration of 26 months. CONCLUSIONS: Withania somnifera has potential against cancer-related fatigue, in addition to improving the quality of life. However, further study with a larger sample size in a randomized trial is warranted to validate our findings.

Integrity signals

Registry

Crossref · 10.1177/1534735412464551

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 33 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Biswal, B. M., Sulaiman, S. A., Ismail, H. C., Zakaria, H., & Musa, K. I.
Affiliations
Universiti Sains Malaysia (MY)
Venue
Integrative Cancer Therapies
Published
2012-11-09
Volume
12
Issue
4
Pages
312-322
ISSN
  • 1534-7354 (ISSN-L)
  • 1552-695X
OpenAlex
W1986443532
Cited by
131
References
33
Citations by year
2026: 13 · 2025: 18 · 2024: 10 · 2023: 7 · 2022: 13 · 2021: 13 · 2020: 12 · 2019: 8 · 2018: 6 · 2017: 12 · 2016: 2 · 2015: 8 · 2014: 7 · 2013: 2
FWCI
13.19
Type
journal article
Language
en
Open access
Locations
  • Integrative Cancer Therapies (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Phytochemicals and Medicinal Plants
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
Keywords
Withania somnifera, breast cancer, chemotherapy-induced fatigue, cancer-related fatigue, quality of life, complementary and alternative medicine, root extract, EORTC QLQ-C30, Piper Fatigue Scale, overall survival
MeSH terms
Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Fatigue, Female, Humans, Phytotherapy, Middle Aged, Plant Extracts, Quality of Life, Treatment Outcome, Withania, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review